FDA.reportPublic FDA data

saxagliptin 5 MG (as saxagliptin HCl, anhydrous 5.58 MG) Oral Tablet

RxCUI
858036
RxNorm name
saxagliptin 5 MG (as saxagliptin HCl, anhydrous 5.58 MG) Oral Tablet
Display name
saxagliptin 5 MG (as saxagliptin HCl, anhydrous 5.58 MG) Oral Tablet
Full name
saxagliptin 5 MG (as saxagliptin HCl, anhydrous 5.58 MG) Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SAXAGLIPTINSAXAGLIPTINGlenmark Pharmaceuticals Inc., USAe286ffd4-c598-47fb-af06-2e15f7e6f99f2026-01-27Warnings, Adverse reactionsExact identifier
rxcui: 858036
SaxagliptinSAXAGLIPTINMylan Pharmaceuticals Inc.6e8d8c4f-96eb-4b64-9c8c-4a5448a23a782025-02-28Warnings, Adverse reactionsExact identifier
rxcui: 858036
SaxagliptinSAXAGLIPTINAurobindo Pharma Limitedf3ea58bb-0002-4a5d-9213-7e9066e3dc9c2024-12-04Warnings, Adverse reactionsExact identifier
rxcui: 858036

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 4 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
6e8d8c4f-96eb-4b64-9c8c-4a5448a23a78sAXagliptin 5 MG Oral Tablet [PSN] · saxagliptin 5 MG Oral Tablet [SCD] · saxagliptin 5 MG (as saxagliptin HCl, anhydrous 5.58 MG) Oral Tablet [SY]34These highlights do not include all the information needed to use SAXAGLIPTIN TABLETS safely and effectively. See full prescribing information for SAXAGLIPTIN TABLETS . SAXAGLIPTIN tablets, for oral use Initial U.S. Approval: 200920250228
f3ea58bb-0002-4a5d-9213-7e9066e3dc9csAXagliptin 5 MG Oral Tablet [PSN] · saxagliptin 5 MG Oral Tablet [SCD] · saxagliptin 5 MG (as saxagliptin HCl, anhydrous 5.58 MG) Oral Tablet [SY]33These highlights do not include all the information needed to use SAXAGLIPTIN TABLETS safely and effectively. See full prescribing information for SAXAGLIPTIN TABLETS. SAXAGLIPTIN tablets, for oral use Initial U.S. Approval: 200920241204
d45fc842-2563-4421-86af-a55b3191e19bsAXagliptin 5 MG Oral Tablet [PSN] · saxagliptin 5 MG Oral Tablet [SCD] · saxagliptin 5 MG (as saxagliptin HCl, anhydrous 5.58 MG) Oral Tablet [SY]33These highlights do not include all the information needed to use ONGLYZA safely and effectively. See full prescribing information for ONGLYZA. ONGLYZA (saxagliptin) tablets Initial U.S. Approval: 200920120109
e286ffd4-c598-47fb-af06-2e15f7e6f99fsAXagliptin 5 MG Oral Tablet [PSN] · saxagliptin 5 MG Oral Tablet [SCD] · saxagliptin 5 MG (as saxagliptin HCl, anhydrous 5.58 MG) Oral Tablet [SY]32These highlights do not include all the information needed to use SAXAGLIPTIN TABLETS safely and effectively. See full prescribing information for SAXAGLIPTIN TABLETS. SAXAGLIPTIN tablets, for oral use Initial U.S. Approval: 200920260127